COVID-19

FDA/TGA Had No Idea How To Assess An mRNA Therapy Product

What’s your Reaction?

LeftNeutralRight

A freedom of information request to the TGA (Australian version of the FDA) just released confirms that they had no idea how to assess an mRNA therapy product.

Dr David Wiseman’s background is in pharmacology. He asks a reasonable question: How qualified are the FDA to investigate a biologic transfectant when most of the “scientists” don’t know what a 3’UTR is, or what pseudouridine does.

A similar question was asked of the Australian Therapeutic Goods Administration.

It is clear that the process of approval was not fit for purpose. Yet nobody said anything. They just took the fee and rubber stamped the approval.

This is damning!

Social Media:

What’s your Reaction?

LeftNeutralRight

7 Comments
To Top